EMAIL THIS PAGE TO A FRIEND

Oncotarget

Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.


PMID 25261371

Abstract

The three oncogenes, ErbB receptors, Ras proteins and nucleolin may contribute to malignant transformation. Previously, we demonstrated that nucleolin could bind both Ras protein and ErbB receptors. We also showed that the crosstalk between the three proteins facilitates anchorage independent growth and tumor growth in nude mice, and that inhibition of this interaction in prostate and colon cancer cells reduces tumorigenicity. In the present study, we show that treatment with Ras and nucleolin inhibitors reduces the oncogenic effect induced by ErbB1 receptor in U87-MG cells. This combined treatment enhances cell death, reduces cell proliferation and cell migration. Moreover, we demonstrate a pivotal role of nucleolin in ErbB1 activation by its ligand. Nucleolin inhibitor prevents EGF-induced receptor activation and its downstream signaling followed by reduced proliferation. Furthermore, inhibition of Ras by Salirasib (FTS), mainly reduces cell viability and motility. The combined treatment, which targets both Ras and nucleolin, additively reduces tumorigenicity both in vitro and in vivo. These results suggest that targeting both nucleolin and Ras may represent an additional opportunity for inhibiting cancers, including glioblastoma, that are driven by these oncogenes.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

32900
Benalaxyl-M, PESTANAL®, analytical standard
C20H23NO3
B6768
Boric acid, BioReagent, for molecular biology, suitable for cell culture, suitable for plant cell culture, ≥99.5%
H3BO3
B7901
Boric acid, for electrophoresis, ≥99.5%
H3BO3
B2645
Boric acid, tablet, 1 g boric acid per tablet
H3BO3
B9645
Boric acid, cell culture tested, plant cell culture tested, ≥99.5%
H3BO3
B1934
Boric acid, Biotechnology Performance Certified, ≥99.5% (titration), Cell Culture Tested
H3BO3
202878
Boric acid, 99.999% trace metals basis
H3BO3
339067
Boric acid, 99.97% trace metals basis
H3BO3
B7660
Boric acid, BioXtra, ≥99.5%
H3BO3
B0394
Boric acid, ACS reagent, ≥99.5%
H3BO3
B0252
Boric acid, ReagentPlus®, ≥99.5%
H3BO3
15663
Boric acid, BioUltra, for molecular biology, ≥99.5% (T)
H3BO3
31146
Boric acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., buffer substance, ≥99.8%
H3BO3
11607
Boric acid, puriss., meets analytical specification of Ph. Eur., BP, NF, 99.5-100.5%, powder
H3BO3
426148
Boric acid-11B, ≥99 atom % 11B
H311BO3
M9140
Methylene blue, certified by the Biological Stain Commission
C16H18ClN3S · xH2O
03978
Methylene Blue solution, for microscopy, concentrate according to Ehrlich, concentrated, aqueous solution
C16H18ClN3S
1808
Methylene Blue solution, 1.4 % (w/v) in 95% ethanol
C16H18ClN3S
319112
Methylene Blue solution, 0.05 wt. % in H2O
C16H18ClN3S
77515
Methylene Blue solution, for microscopy
C16H18ClN3S
50484
Methylene Blue solution, for microbiology
C16H18ClN3S
66725
Methylene Blue solution alkaline according to Loeffler, according to Loeffler
C16H18ClN3S